2010China Modern DoctorRequires access

Aplication of Sertraline in Treatment Post-stroke Depression:A 32 Cases Clinical Study

Wei Rongce

Open publisher page 0 citations

Abstract

Objective To explore the clinical efficacy of sertraline treatment post-stroke depression,and compared with amitriptyline.Methods Sixty-four cases post-stroke depression were randomly divided into treatment group(sertraline group) and the control group(amitriptyline group),to obseve efficacy and adverse reactions after 8 weeks by adopting Hamilton Dalton Depression Scale(HAMD)Evaluation.Results After 8 weeks,the treatment group response rate was 87.5%,and the control group response rate was 59.4%,by statistical analysis,there was significant difference between two groups(P0.05).The HAMD scores were(9.34 ± 5.97)points,(12.59±5.53)points(P0.05):The adverse reactions were significant difference(P0.05).Conclusion Sertraline treatment of depression more satisfactory efficacy,adverse reactions compared with amitriptyline light,safe and effective,worthy of clinical practice and application.

About this research paper

What this paper is about

Objective To explore the clinical efficacy of sertraline treatment post-stroke depression,and compared with amitriptyline.Methods Sixty-four cases post-stroke depression were randomly divided into treatment group(sertraline group) and the control group(amitriptyline group),to obseve efficacy and adverse reactions after 8 weeks by adopting Hamilton Dalton Depression Scale(HAMD)Evaluation.Results After 8 weeks,the treatment group response rate was 87.5%,and the control group response rate was 59.4%,by statistical analysis,there was significant difference between two groups(P0.05).The HAMD scores were(9.34 ± 5.97)points,(12.59±5.53)points(P0.05):The adverse reactions were significant difference(P0.05).Conclusion Sertraline treatment of depression more satisfactory efficacy,adverse reactions compared with amitriptyline light,safe and effective,worthy of clinical practice and application.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To explore the clinical efficacy of sertraline treatment post-stroke depression,and compared with amitriptyline.Methods Sixty-four cases post-stroke depression were randomly divided into treatment group(sertraline group) and the control group(amitriptyline group),to obseve efficacy and adverse reactions after 8 weeks by adopting Hamilton Dalton Depression Scale(HAMD)Evaluation.Results After 8 weeks,the treatment group response rate was 87.5%,and the control group response rate was 59.4%,by statistical analysis,there was significant difference between two groups(P0.05).The HAMD scores were(9.34 ± 5.97)points,(12.59±5.53)points(P0.05):The adverse reactions were significant difference(P0.05).Conclusion Sertraline treatment of depression more satisfactory efficacy,adverse reactions compared with amitriptyline light,safe and effective,worthy of clinical practice and application.

Key concepts: Hamd, Sertraline, Medicine, Post-stroke depression, Depression (economics), Amitriptyline, Hamilton depression scale, Clinical efficacy

Related papers

Back to paper searchBrowse research topicsOriginal source
Aplication of Sertraline in Treatment Post-stroke Depression:A 32 Cases Clinical Study — Research Paper | ScholarLens